Results 111 to 120 of about 14,446 (149)

Lorlatinib in advanced ALK-positive NSCLC after prior progression on ALK inhibitors: real-world experience in Russia. [PDF]

open access: yesExplor Target Antitumor Ther
Orlov SV   +9 more
europepmc   +1 more source

Présentation : les compétences civiles, entre État sécuritaire et État social

open access: yesLien Social et Politiques, 2007
Julie-Anne Boudreau, Philippe Estèbe
doaj   +1 more source

CHD4 and NOX4 expression in thyroid tumor tissues. [PDF]

open access: yesExplor Target Antitumor Ther
Fenniche S   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy